Resverlogix Corp T.RVX

re - Not good for the potential of apabetalone as a Covid-19

[general360]

not sure Bear looks at stockhouse any longer, but he just posted this on agoracommie

https://agoracom.com/ir/Resverlogix/forums/discussion/topics/770557-not-good-for-the-potential-of-apabetalone-as-a-covid-19-therapy/messages/2338952#message

wondering about the significance of this... a couple things caught my eye in the abstract he posted:

in the Summary section there is this line "Knockouts of BRD3 or BRD4 in cells overexpressing ACE2 exacerbate SARS-CoV-2 infection; "

and in the discussion portion this:  "Because most BET inhibitors do not distinguish between the different BET proteins and inhibit all of them indiscriminately, our study urges caution with the clinical use, prophylactic or therapeutic, of pan-BET inhibitors in people at risk or afflicted with COVID-19."

that doesn't jive w/ my understanding:

thought we were NOT a pan-BET inhibitor? 
thought we hit BRD4, not both BRD3 and BRD4?  or was it BRD2 and not both BRD3 and BRD4?

am i missing something?  maybe someone can ask Bear on agora? i would think this would be *good* for us?!

maybe that's why we languish....

thx.....

[narmac]

,,yea,,,boooyyy,,,hammer that share price,,,hammer it big time!!!!,,,,,,sell those shares into the market at what ever the bid is on the board,,,,these achievments from our team will certainly garner more DSUs and RSUs next quarter,,,wooohoooo!!! ,,,this company is nothing short of a joke,,,,

[narmac]

Hummmmm,,,,,Notice more often than not,,,,,when RVX gets hammered BTI goes up,,,,,I assume shareholders are taking $$$ off red and puting it on black for this round!!

[general360]

what a nice close that was..... the DM effect?  a result of Bear's posting something not good for RVX chances vs COVID?  a financing coming? a full TEN PERCENT, way to go team! u get RSU's and u get RSU's....... the butterfly effect... a butterfly flaps its wings in indonesia and poof, causes a hurricane in mexico....if the rvx butterfly flaps his gums in say, north africa

[narmac]

aaaccchhhhh,,,,its a sure thing DMcC is not the guy doing business,,,he is the talking head for this outfit. No non-professional is courting any bioitech or biotech service or other in cutting edge science protocol. I just dont believe it,,,,,I think our CEO is not even part of the meetings at times,,,,it looks that way cuz what he thinks he knows as being fact is actually gibberish from a

[BearDownAZ]

"thought we were NOT a pan-BET inhibitor? thought we hit BRD4, not both BRD3 and BRD4?  or was it BRD2 and not both BRD3 and BRD4?" My understanding of the published characterization of apabetalone is that it is not selective to BRD2, BRD3 or BRD4; however, it is more selective for binding to and inhibiting the second bromodomain (BD2) than BD1 irrespective of BRD2, BRD3 or